BeautyHealth stock price has fallen with operating losses and declining EPS, analysts recommend caution.

From StockStory Media: 2024-12-25 04:10:25

BeautyHealth’s stock price has fallen to $1.49 over the past six months, resulting in an 18.1% loss for shareholders. Despite a more attractive entry price, the company is experiencing operating losses with an average operating margin of negative 26.1%. Additionally, EPS has declined by 58% annually over the last three years, and the company’s short cash runway raises concerns about potential shareholder dilution. As a result, analysts recommend caution with BeautyHealth and suggest exploring other investment opportunities. For a more promising option, consider looking into TransDigm, a dominant Aerospace business with a successful M&A strategy.



Read more at StockStory Media: Three Reasons to Avoid SKIN and One Stock to Buy Instead